News from CPhI
India will stamp out "fly by night operators" in trial industry, says Gov
The Indian Government will stamp out “fly by night operators” in its clinical trials sector by plugging "loopholes" in the regulations.
News from CPhI
The Indian Government will stamp out “fly by night operators” in its clinical trials sector by plugging "loopholes" in the regulations.
The bioavailability market lacks a leader that can offer comprehensive solutions according to Merck Millipore, which has set its sights on filling the gap through investments and a new lab.
Pfizer is re-jigging its failed virtual trial model and could re-launch the programme as soon as 2013.
The USP has delayed new elemental impurities standards but is still confident they can be harmonized with ICH Q3D even if May 2014 implementation target is kept.
Rhenovia Pharma says the multi-drug delivery capabilities of its transdermal-patch could have wider application.